Publications by authors named "Yunqin Ma"

Claim this Profile
T
The impact of chiglitazar, a pan-PPAR agonist, on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: a real-world study.
Yijiong Tan, Wenjun Qu, Jiehua Zhao, Yunqin Ma, Qidi Zhang

Diabetes Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
USP13 ameliorates metabolic dysfunction-associated steatohepatitis through targeting PTEN.
Min Tang, Xiaohui Wei, Yunqin Ma, Yijiong Tan, Han Cao

Life Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
USP13 ameliorates nonalcoholic fatty liver disease through inhibiting the activation of TAK1.
Min Tang, Han Cao, Yunqin Ma, Shuangshuang Yao, Xiaohui Wei

J Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of G0/G1 switch gene 2 by endoplasmic reticulum stress enhances hepatic steatosis.
Yunqin Ma, Mingliang Zhang, Haoyong Yu, Junxi Lu, Kenneth K Y Cheng

Metabolism· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-ALA ameliorates hepatic steatosis through AMPK signaling pathway.
Haoyong Yu, Mingliang Zhang, Yunqin Ma, Junxi Lu, Jiemin Pan

J Mol Endocrinol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis